00:01
Hi, I'm Doctor Rhonda Lawes and this is the
discussion on the use of non stimulants in
the treatment of ADHD.
00:08
Specifically we're going to look at alpha
two adrenergic agonists.
00:12
Now the two examples we're going to use here
are clonidine and guanfacine.
00:17
Okay. So we've got those two as example
drugs.
00:19
But these medications since they're agonists
they're going to stimulate the alpha two
receptors. Now most predominantly the alpha
two receptors that are in the prefrontal
cortex. That's good news for those with ADHD
because that will help with those executive
functioning kind of skills.
00:35
So clonidine stimulates the alpha two A, the
alpha two B and the alpha two C receptors.
00:41
Specifically Guanfacine selectively
stimulates the alpha two receptors.
00:47
Now why does this matter to you?
Well, you're going to have fewer side
effects with guanfacine because it has a
higher selectivity for the alpha two
receptors.
00:56
You're going to have more side effects with
the clonidine because it hits the alpha two
A, two b, and the two c.
01:03
Let's look at the at the physiological
effects by the receptors.
01:07
Now the presynaptic receptors are different
than what you'll see in the postsynaptic
receptors. But starting with the presynaptic
receptors it's going to be primarily the
alpha two subtype.
01:18
Now when you hit those alpha two receptors
they're the main mediators of the effects of
the norepinephrine.
01:24
Now this helps the client with inattention,
hyperactivity and impulsivity.
01:29
So that's what they benefit from the
activation of the Alpha two A's.
01:34
Now the alpha two receptors are particularly
found in the cortex and the locus coeruleus.
01:40
Now let's look at the postsynaptic receptors
alpha two A, B and C and also the alpha one
subtypes of alpha one a, one b and one d.
01:52
So take away points from here.
01:54
There's different specific receptors in the
presynaptic receptors and the postsynaptic
receptors. And you've learned where we have
the highest function of the two A's where
it's located. And that they're the main
mediators of Of norepinephrine.
02:08
So your clients are going to have a better
opportunity to pay attention.
02:12
Deal with the hyperactivity symptoms and
impulsivity.
02:15
Now the adverse effects of the alpha two is
the most prominent ones are going to be the
sedation. Remember you're going to have more
side effects with clonidine than you will
with guanfacine because guanfacine is more
selective.
02:27
But the most prominent you're going to have
sedation.
02:29
They may also have orthostatic hypotension.
02:32
So remind them about safety.
02:34
If they're jumping up quickly they're going
to get a little dizzy.
02:37
It can also slow down the heart rate.
02:39
It can be bradycardia.
02:40
They may show some depression, some change
in mood and they may complain of headache.
02:46
So these are the most prominent ones the
ones you're most likely to see.
02:50
Now how do you know when you should use this
or when you should absolutely not use the
alpha two adrenergic agonist?
Well, this is used for the treatment of ADHD
in children who are at least six years of
age. You can also use it with adolescents
and with adults.
03:05
The people it is contraindicated to use this
with are the following If the client is
hypersensitive to any part of this type of
medication, then you obviously wouldn't want
to prescribe it. If the patient is
cardiovascular or cerebral vascular disease,
you would also want to be very cautious.
03:23
If you choose to give that.
03:24
This would require really thorough
assessment to this patient.
03:28
Now last, if this client is on another alpha
two agonist, you don't want to prescribe an
additional alpha two agonist to treat the
ADHD.
03:38
Now there are some additional indications or
use cases for alpha two adrenergic agonists.
03:43
So usually think about reserving them for
patients if they have any of the following
situations. So if the patient has difficulty
initiating sleep these are good drugs.
03:53
Remember they can cause that sleepiness.
03:55
If the client's had a poor response to a
trial of a stimulant or an snri.
04:00
This might be a drug you'd want to consider
prescribing.
04:02
Now, if the patient experienced unacceptable
adverse effects with other medications, this
is an option.
04:08
If the patient has a significant co-existing
condition, they may want to want to choose an
alpha two rather than a type of stimulant.
04:16
Now, if the patient has some other
contraindication to stimulants, again, you
would want to try an alpha two adrenergic
agonist.
04:23
And finally, if the patient has tics or
Tourette's, this would not be a good choice
to give them a stimulant.
04:29
And so an alpha two adrenergic agonist might
be applicable.
04:34
So keep in mind these can be used in ADHD.
04:37
But as a class they're not as effective as
stimulants.
04:41
But they definitely have a place in your
toolbox for clients who need to try an
alternative. Now, when it comes to
prescribing and termination, let's look at
what you'll do as a provider.
04:51
You'll need to educate your patients that it
could take up to two weeks for them to really
experience a kind of response to this
medication.
04:58
So make sure you set their expectations
appropriately and let them know it's going to
be a while before they may notice a
difference.
05:04
Obviously, you're going to want to start at
a low dose, typically at bedtime, because of
the potential for sedation.
05:10
Now you're going to titrate to the desired
effect.
05:13
And this will involve communication with
your client.
05:16
This is not a medication that you'll need to
take drug holidays.
05:19
They'll need to keep taking this every day.
05:22
Now, when it comes to discontinuing or
terminating the script, make sure you try to
avoid an abrupt discontinuation.
05:29
You want to taper this gradually.
05:31
You want to wean the medication so that you
avoid significant rebound hypertension or
nervousness. Now be aware that withdrawal
symptoms you can treat them by up titrating
the medication again and then tapering it.
05:44
But this time do it more gradually to avoid
those withdrawal symptoms.
05:49
Now we created this study chart for you and
this will help you compare clonidine and
guanfacine. Remember those are two alpha
adrenergic agonists that we're using as
examples. So take a look at the chart.
06:00
Hey sometimes charts can be so helpful, but
they don't really work unless you spend some
time working with them.
06:06
So across the top let's get oriented.
06:09
The name of the medication.
06:10
So you see we have both clonidine and
guanfacine.
06:13
We have the available formulations right.
06:16
And then you have the typical titration
schedule.
06:19
Now for clonidine.
06:20
You can have either an oral tablet or a
transdermal patch.
06:24
Now for the tablets. They come in immediate
release or extended release.
06:28
But if you look at the typical titration
schedule, you see they're exactly the same.
06:33
Both of these are nightly dosing.
06:35
You can titrate them every two weeks with a
maximum dose of 0.4mg daily.
06:41
So those are the oral tablets.
06:43
Now clonidine also comes in the form of a
transdermal patch.
06:47
Now this would typically not be your first
choice to start someone on clonidine for
ADHD. With a transdermal patch.
06:54
But it might be a good idea to convert them
from the oral formation once you've got them
on an optimal stable dose.
07:02
Now let's take a look at guanfacine.
07:03
Now you see it's an oral tablet.
07:05
Same thing. You have immediate release and
extended release.
07:08
Now, with the immediate release, you're going
to start with nightly dosing.
07:11
And then you can increase the frequency up
to four times a day.
07:15
You start with a nightly dose to kind of let
them adjust to that sedative effect.
07:19
And then you can gradually add the extra
doses.
07:22
Now you can titrate every two weeks, so you
don't want to make a change until they've had
two weeks on that dosage.
07:28
And then you can start titrating it up.
07:30
Now, the maximum dose of four milligrams is
what you use for children less than 12 years
of age, and seven milligrams for adolescents
and adults.
07:39
Now, with the extended release tablets, you
can also up titrate those every two weeks.
07:44
Now, once daily dosing can be a max of four
milligrams for children that are less than 12
years of age, and again, seven milligrams
for adolescents or adults.
07:55
Now, while you have this chart, make sure
you take a look at the things that are
similar as we did when you and I were
studying and walking through it together.
08:02
And the things that are different that will
help you force that information into your
longer term memory.
08:09
So you can recall it when you need it.
08:11
Now, I wanted to go over at the very bottom,
look at extended release and immediate
release. Tablets have different
pharmacokinetic properties, so don't
substitute them on a milligram per milligram
basis.
The lecture ADHD Nonstimulants: Alpha-2-Adrenergic Agonists by Rhonda Lawes, PhD, RN is from the course ADHD Treatment Guidelines.
Which brain region contains the primary alpha-2 receptors targeted in ADHD treatment?
Which condition most strongly indicates using an alpha-2 agonist over stimulants?
What distinguishes guanfacine from clonidine?
What is the recommended approach for stopping alpha-2 agonist therapy?
5 Stars |
|
5 |
4 Stars |
|
0 |
3 Stars |
|
0 |
2 Stars |
|
0 |
1 Star |
|
0 |